PayPay Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01K Sell
6
-1
-14% -$480 0.07% 140
2026
Q1
$3.61K Sell
7
-1
-13% -$543 0.13% 127
2025
Q4
$4.64K Sell
8
-1
-11% -$566 0.14% 119
2025
Q3
$4.54K Buy
9
+2
+29% +$931 0.16% 96
2025
Q2
$2.84K Sell
7
-1
-13% -$418 0.14% 108
2025
Q1
$4.25K Sell
8
-2
-20% -$1.08K 0.24% 79
2024
Q4
$5.2K Buy
10
+1
+11% +$550 0.23% 68
2024
Q3
$5.57K Buy
9
+2
+29% +$1.18K 0.5% 45
2024
Q2
$3.87K Hold
7
0.32% 78
2024
Q1
$4.07K Sell
7
-1
-13% -$561 0.2% 101
2023
Q4
$4.26K Buy
8
+3
+60% +$1.45K 0.21% 98
2023
Q3
$552 Hold
5
0.03% 186
2023
Q2
$2.61K Sell
5
-5
-50% -$2.7K 0.16% 101
2023
Q1
$5.76K Sell
10
-5
-33% -$2.82K 0.39% 45
2022
Q4
$8.26K Buy
+15
New +$7.95K 0.55% 40

Other funds holding TMO

PayPay Securities's TMO Position: Q2 2026 in Review

PayPay Securities reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $480 and leaving 6 shares worth $3.01K. The position accounts for 0.07% of the portfolio, ranked #140.

PayPay Securities first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.26K in Q4 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • PayPay Securities held 6 shares of Thermo Fisher Scientific worth $3.01K as of Q2 2026.
  • PayPay Securities sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.07% of PayPay Securities's portfolio in Q2 2026, its #140 holding.
  • PayPay Securities first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's Thermo Fisher Scientific position peaked at $8.26K in Q4 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.